152 related articles for article (PubMed ID: 16499874)
1. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
Zhang Q; Kang X; Zhao W
Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
Kang XM; Zhang QY; Tong DD; Zhao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
5. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Touil YS; Seguin J; Scherman D; Chabot GG
Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336
[TBL] [Abstract][Full Text] [Related]
6. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
Qiu M; Yi C; Hou M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):534-7. PubMed ID: 16909595
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice.
Zhang Q; Kang X; Yang B; Wang J; Yang F
Cancer Biother Radiopharm; 2008 Oct; 23(5):647-53. PubMed ID: 18999937
[TBL] [Abstract][Full Text] [Related]
8. [Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma].
Huang X; Hou M; Yi C; Song H
Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):132-6. PubMed ID: 21144297
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y; Teicher BA
Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
11. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
Yap R; Veliceasa D; Emmenegger U; Kerbel RS; McKay LM; Henkin J; Volpert OV
Clin Cancer Res; 2005 Sep; 11(18):6678-85. PubMed ID: 16166447
[TBL] [Abstract][Full Text] [Related]
12. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.
Wietrzyk J; Boratynski J; Grynkiewicz G; Ryczynski A; Radzikowski C; Opolski A
Anticancer Res; 2001; 21(6A):3893-6. PubMed ID: 11911265
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic effect of ginsenoside Rg3 in ICR mouse primary cultures and its application to a biological response modifier.
Joo SS; Won TJ; Kim MS; Lee DI
Fitoterapia; 2004 Jun; 75(3-4):337-41. PubMed ID: 15158992
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.
Herbst RS; Takeuchi H; Teicher BA
Cancer Chemother Pharmacol; 1998; 41(6):497-504. PubMed ID: 9554595
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.
Wang Z; Zheng Q; Liu K; Li G; Zheng R
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):411-5. PubMed ID: 16623867
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of ginsenoside Rg3 (Review).
Sun M; Ye Y; Xiao L; Duan X; Zhang Y; Zhang H
Int J Mol Med; 2017 Mar; 39(3):507-518. PubMed ID: 28098857
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
Jiang JW; Chen XM; Chen XH; Zheng SS
World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Anderson IC; Shipp MA; Docherty AJ; Teicher BA
Cancer Res; 1996 Feb; 56(4):715-8. PubMed ID: 8631001
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor model.
Ishida T; Shiraga E; Kiwada H
J Control Release; 2009 Mar; 134(3):194-200. PubMed ID: 19095022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
